Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Trastornos del Movimiento
FILTRAR POR:
Por tema
4562 ARTÍCULOS , VIENDO DEL 3961 AL 3975
Breaking down autophagy and the Ubiquitin Proteasome System
Jung S, Chung Y, Oh YJ.
Parkinsonism Relat Disord. 2018 Jan;46 Suppl 1:S97-S100. doi: 10.1016/j.parkreldis.2017.07.026. Epub 2017 Jul 26.
The role of the basal ganglia in the control of seizure
Vuong J, Devergnas A.
J Neural Transm (Vienna). 2018 Mar;125(3):531-545. doi: 10.1007/s00702-017-1768-x. Epub 2017 Aug 1.
Recent developments in understanding the role of the gut microbiota in brain health and disease
Sherwin E, Dinan TG, Cryan JF.
Ann N Y Acad Sci. 2018 May;1420(1):5-25. doi: 10.1111/nyas.13416. Epub 2017 Aug 2.
Parkinson's disease pathogenesis from the viewpoint of small fish models
Matsui H, Takahashi R.
J Neural Transm (Vienna). 2018 Jan;125(1):25-33. doi: 10.1007/s00702-017-1772-1. Epub 2017 Aug 2.
Multiple System Atrophy: Many Lessons from the Transcriptome
Curry-Hyde A, Chen BJ, Ueberham U, Arendt T, Janitz M.
Neuroscientist. 2018 Jun;24(3):294-307. doi: 10.1177/1073858417723915. Epub 2017 Aug 3.
The PMR1 pump in alpha-synuclein toxicity and neurodegeneration
Nikoletopoulou V, Tavernarakis N.
Neurosci Lett. 2018 Jan 10;663:66-71. doi: 10.1016/j.neulet.2017.08.006. Epub 2017 Aug 2.
Neuropathology of Parkinson disease
Dickson DW.
Parkinsonism Relat Disord. 2018 Jan;46 Suppl 1(Suppl 1):S30-S33. doi: 10.1016/j.parkreldis.2017.07.033. Epub 2017 Aug 1.
Biomarkers for cognitive dysfunction in Parkinson's disease
Kalia LV.
Parkinsonism Relat Disord. 2018 Jan;46 Suppl 1:S19-S23. doi: 10.1016/j.parkreldis.2017.07.023. Epub 2017 Jul 24.
The future burden of Parkinson's disease
Rocca WA.
Mov Disord. 2018 Jan;33(1):8-9. doi: 10.1002/mds.27114. Epub 2017 Aug 7.
The 200-year journey of Parkinson disease: Reflecting on the past and looking towards the future
Fahn S.
Parkinsonism Relat Disord. 2018 Jan;46 Suppl 1:S1-S5. doi: 10.1016/j.parkreldis.2017.07.020. Epub 2017 Aug 1.
Patient and Physician Perceptions of Virtual Visits for Parkinson's Disease: A Qualitative Study
Mammen JR, Elson MJ, Java JJ, Beck CA, Beran DB, Biglan KM, Boyd CM, Schmidt PN, Simone R, Willis AW, Dorsey ER.
Telemed J E Health. 2018 Apr;24(4):255-267. doi: 10.1089/tmj.2017.0119. Epub 2017 Aug 1.
Untangling the tauopathies: Current concepts of tau pathology and neurodegeneration
Ling H.
Parkinsonism Relat Disord. 2018 Jan;46 Suppl 1:S34-S38. doi: 10.1016/j.parkreldis.2017.07.031. Epub 2017 Aug 1.
Familial manganese-induced neurotoxicity due to mutations in SLC30A10 or SLC39A14
Mukhopadhyay S.
Neurotoxicology. 2018 Jan;64:278-283. doi: 10.1016/j.neuro.2017.07.030. Epub 2017 Aug 5.
Terrens AF, Soh SE, Morgan PE.
Disabil Rehabil. 2018 Dec;40(24):2847-2856. doi: 10.1080/09638288.2017.1362710. Epub 2017 Aug 9.
Historical perspective: The pros and cons of conventional outcome measures in Parkinson's disease
Lim SY, Tan AH.
Parkinsonism Relat Disord. 2018 Jan;46 Suppl 1:S47-S52. doi: 10.1016/j.parkreldis.2017.07.029. Epub 2017 Jul 29.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.